Method and system for monitoring a diabetes treatment plan
US11793471B2 · kind B2 · utility
Inventor
Key dates
| Filing date | Jun 20, 2017 |
| Grant date | Oct 24, 2023 |
| Priority date | — |
| Expiry date | Aug 11, 2037 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG16H50/70
- WIPO fieldMedical technology
- WIPO sectorInstruments
Abstract
A method and system for monitoring the effectiveness of a patient's diabetes treatment plan by predicting, on a frequent basis, the patient's glycated hemoglobin (A1c) based on the patient's blood glucose (BG) may include applying a plurality of A1c models to a BG data set of the patient so as to obtain a plurality of calculated A1c values and identifying a best fit model amongst the plurality of A1c models by evaluating the plurality of calculated A1c values against at least one measured A1c value; calculating a predicted A1c value by applying the identified best fit model to the BG data set. Some embodiments may further include evaluating the predicted A1c value against a set of escalation rules to determine whether an escalation alert is required; alerting the patient's healthcare provider when it is determined the escalation alert is required; and outputting the predicted A1c value to the patient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.